Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Patients With Relapsing-Remitting Multiple Sclerosis (CombiRx)

NCT00211887 is registered in ClinicalTrials.gov with Fred Lublin as lead sponsor.

NCT NCT00211887
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00211887 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multi-Center, Double-Blind, Randomized Study Comparing the Combined Use of Interferon Beta-1a and Glatiramer Acetate to Either Agent Alone in Patients With Relapsing-Remitting Multiple Sclerosis (CombiRx)
Lead sponsor
Fred Lublin
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2005
Completion date
March 31, 2013
Enrollment
1,008 (actual)
Sites
71

Conditions

As the registry lists them; a condition with its own page is linked.

relapsing remitting multiple sclerosis